
原料药
Risperidone
KDMF APIs
Risperidone
韩文名称 | 리스페리돈 |
|---|---|
分类 | 中枢神经系统药物 |
CAS No. | 106266-06-2 |
KDMF 登记号 | 20151130-10-C-349-20 20070521-10-C-231-14(1) |
生产厂商 | Mylan Laboratories Limited Aurobindo Pharma ltd. |
规格 | EP |
品目信息
IUPAC Name | RAPZEAPATHNIPO-UHFFFAOYSA-N |
|---|---|
Description | Risperidone is a second-generation antipsychotic (SGA) medication used in the treatment of a number of mood and mental health conditions including schizophrenia, bipolar mania, and as an adjunct in severe depression for example. It is one of the most widely used SGAs. Schizophrenia and various mood disorders are thought to be caused by an excess of dopaminergic D2 and serotonergic 5-HT2A activity, resulting in overactivity of central mesolimbic pathways and mesocortical pathways, respectively. Risperidone is thought to reduce this overactivity through inhibition of dopaminergic D2 receptors and serotonergic 5-HT2A receptors in the brain. Risperidone binds with a very high affinity to 5-HT2A receptors, approximately 10-20 fold greater than the drug's binding affinity to D2 receptors |
Certificate of Analysis | If you need more information, please contact us. |
如需规格书 · 检验成绩书等附加资料,请在咨询时一并提出。负责人确认后将回复您。(02-579-1056 · ace@acebiopharm.com)